Sponsor pipeline

Maastricht University Medical Center clinical trial pipeline

Get alerts when Maastricht University Medical Center's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

11 trials changed in the last 30 days: 0 stopped, 5 with notable changes, 6 with minor changes only.

  1. Notable

    Primary completion pushed from May 1, 2028 to Jan 1, 2029

    Also in this update: Primary endpoint(s) modified; Study completion pushed from May 15, 2028 to May 15, 2029

    Maastricht University Medical CenterNot applicable NCT07287358 Registry history

Show 6 trials with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1/2
1
Phase 2
4
Phase 3
1
Phase 4
2
Not charted: 88 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 30

Breast Cancer (8) · Heart Disease (8) · Obesity (6) · Diabetes (3) · Head & Neck Cancer (3) · Lung Cancer (3) · Atrial Fibrillation (2) · Coronary Artery Disease (2) · Crohn's Disease (2) · Heart Failure (2)

Get alerts when Maastricht University Medical Center's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free